The French company has seen its microbiome therapy for patients living with treatment-induced dysbiosis hit its endpoints.

The dishes come in a set of four and are available in four colors, ranging from white to black. Each one has a smooth texture ...

Around 1,200 people with advanced breast cancer could benefit from a decision by NICE to give the go-ahead to a new treatment ...

Last year, the focus was on creating capsule wardrobes, investing in expert-approved creams, and finding hair loss solutions.

Heather Lynn described the 1120-square-foot home, located in a 1960s Hallcraft townhome community, that she purchased three years ago as “dreary 30-shades-of greige style with only the kitchen and ...

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

Two independent studies reveal that disease progression is delayed by combining two targeted therapies with the traditional ...

Comedian and actress Aida Rodriguez pens a personal essay where she shares how getting diagnosed with ADHD changed her life ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

A recent meta-analysis published in JAMA Psychiatry addresses a common misperception that trauma-focused therapies are ...

The FDA granted rare pediatric disease designation to VG901 for the treatment of retinitis pigmentosa caused by mutations in ...

Bryan Johnson, the founder of Braintree and subject of a new Netflix doc, is on a quest for remarkable longevity.